Skip to contentSkip to Braille Studio

Library / Laws / 114th Congress / House Bills / H.R. 5763

H.R. 5763

To clarify the treatment of certain DNA Specimen Provenance Assay tests as reasonable and necessary for the diagnosis or treatment of illness for coverage under the Medicare program.

Print stageDateSize⠃
Introduced in House—2.0K⠃⠗⠋